Fortrea Holdings Inc.
FTRE
Rank in Stocks
#5752
Fortrea Holdings Inc. functions as a global contract research organization... Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development. The Enabling Services segment, conversely, delivers patient access programs and cutting-edge clinical trial technology solutions, aiming to simplify complex randomization processes and optimize the supply of trial medications for its customers. Fortrea presents a range of engagement options, such as full-service provision, functional service provider (FSP) models, and hybrid structures. Additionally, its portfolio includes managing clinical trials from Phase I through IV, offering distinctive technology-powered trial solutions, and providing post-market approval services. The company's client base primarily consists of pharmaceutical, biotechnology, and medical device entities. Fortrea Holdings Inc. was founded in 2023 and has its headquarters in Durham, North Carolina.
Share Price
$22.24
Last synced: 2026-11-09
Market Cap
$2.10B
Change (1 day)
1.28%
Change (1 year)
88.63%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Fortrea Holdings Inc. (FTRE)
Category
Healthcare
Operating Margin for Fortrea Holdings Inc. (FTRE)
Operating Margin as of November 2026 TTM: 1.57%
According to Fortrea Holdings Inc.'s latest financial reports, its current operating margin (TTM) is 1.57%. At the end of 2025 the company had an operating margin of -1.12%.
Operating Margin history for Fortrea Holdings Inc. from 2020 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 1.57% | -240.18% |
| 2025 | -1.12% | -81.33% |
| 2024 | -6.00% | -630.97% |
| 2023 | 1.13% | -82.85% |
| 2022 | 6.59% | 76.20% |
| 2021 | 3.74% | -130.71% |
| 2020 | -12.18% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -75.42% |
US
|
|
| -149.01% | -194.91% |
US
|
|
| 25.57% | -83.71% |
AU
|
|
| 31.23% | -80.11% |
BE
|
|
| 29.35% | -81.31% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Fortrea Holdings Inc.'s operating margin
What is Fortrea Holdings Inc.'s operating margin?
Fortrea Holdings Inc.'s operating margin is 1.57%, as of Nov 2026.
What was Fortrea Holdings Inc.'s operating margin in 2025?
In 2025, Fortrea Holdings Inc.'s operating margin was -1.12%, compared with -6.00% in 2024.
How has Fortrea Holdings Inc.'s operating margin changed since 2020?
From 2020 to 2025, Fortrea Holdings Inc.'s operating margin was highest in 2022 (6.59%) and lowest in 2020 (-12.18%).
How does Fortrea Holdings Inc.'s operating margin compare with similar companies?
Fortrea Holdings Inc.'s operating margin (1.57%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.